Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Crescent inks GlycoMimetics merger, securing listing and $200M
Crescent is part of the pack of drug developers targeting the PD-1xVEGF bispecific opportunity.
Nick Paul Taylor
Oct 29, 2024 10:20am
GSK aims to extend lupus dominance via $300M T-cell engager deal
Oct 29, 2024 8:00am
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Oct 28, 2024 10:00am
Novartis inks $150M deal for autoimmune molecular glue
Oct 28, 2024 7:00am
AbbVie makes Richter richer, paying $25M to form discovery pact
Oct 25, 2024 7:55am
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am